Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
OPCH 
Option Care Health Inc (OPCH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: OPCH (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
AI Based Fundamental Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Analysis of Past Performance
Type Stock | Historic Profit 4.8% | Avg. Invested days 47 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.82B USD | Price to earnings Ratio 28.39 | 1Y Target Price 37.78 |
Price to earnings Ratio 28.39 | 1Y Target Price 37.78 | ||
Volume (30-day avg) 1875171 | Beta 1.33 | 52 Weeks Range 21.39 - 35.53 | Updated Date 03/27/2025 |
52 Weeks Range 21.39 - 35.53 | Updated Date 03/27/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.24 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.24% | Operating Margin (TTM) 6.46% |
Management Effectiveness
Return on Assets (TTM) 6.06% | Return on Equity (TTM) 14.99% |
Valuation
Trailing PE 28.39 | Forward PE 23.87 | Enterprise Value 6624529827 | Price to Sales(TTM) 1.16 |
Enterprise Value 6624529827 | Price to Sales(TTM) 1.16 | ||
Enterprise Value to Revenue 1.33 | Enterprise Value to EBITDA 16.72 | Shares Outstanding 165316000 | Shares Floating 164097582 |
Shares Outstanding 165316000 | Shares Floating 164097582 | ||
Percent Insiders 0.7 | Percent Institutions 100.98 |
Analyst Ratings
Rating 3.9 | Target Price 29.67 | Buy 3 | Strong Buy 3 |
Buy 3 | Strong Buy 3 | ||
Hold 4 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Option Care Health Inc
Company Overview
History and Background
Option Care Health, Inc. was formed in 2015 through the merger of Walgreens Infusion Services and BioScrip's community-based infusion services business. It provides home and alternate site infusion services.
Core Business Areas
- Infusion Services: Provides infusion therapy services for patients with chronic and acute conditions, including anti-infectives, nutrition support, and immunoglobulin therapy. Services are delivered in patientsu2019 homes or at company-owned infusion centers.
- Specialty Pharmacy Services: Supplies medications and other products needed for infusion therapy. Works with physicians, manufacturers, and payers to ensure patients receive the appropriate treatment.
Leadership and Structure
John C. Rademacher serves as the President and Chief Executive Officer. The company operates with a functional organizational structure focused on clinical services, sales, operations, and finance.
Top Products and Market Share
Key Offerings
- Anti-Infectives: Antibiotics and antifungals administered intravenously or subcutaneously. Competitors include CVS Health (CVS), Walgreens Boots Alliance (WBA), and other regional home infusion providers. Market share information isn't readily available for this specific product, but the broader home infusion market is fragmented.
- Nutrition Support: Parenteral and enteral nutrition therapies for patients unable to receive adequate nutrition orally. Competitors include CVS Health (CVS), Walgreens Boots Alliance (WBA), and other regional home infusion providers. Market share information isn't readily available for this specific product, but the broader home infusion market is fragmented.
- Immunoglobulin Therapy: Intravenous immunoglobulin (IVIG) and subcutaneous immunoglobulin (SCIG) therapies for patients with immune deficiencies and neurological disorders. Competitors include CVS Health (CVS), Walgreens Boots Alliance (WBA), and other regional home infusion providers. Market share information isn't readily available for this specific product, but the broader home infusion market is fragmented.
Market Dynamics
Industry Overview
The home and alternate site infusion market is growing, driven by an aging population, increasing prevalence of chronic diseases, and a shift towards more cost-effective healthcare delivery models.
Positioning
Option Care Health is a leading independent provider of home and alternate site infusion services, differentiating itself through its focus on clinical expertise and patient care.
Total Addressable Market (TAM)
The total addressable market is estimated to be in the tens of billions of dollars annually. Option Care Health is positioned to capture a significant share of this market through its extensive network and clinical capabilities.
Upturn SWOT Analysis
Strengths
- National network of infusion pharmacies and centers
- Strong relationships with payers and manufacturers
- Experienced management team
- Focus on clinical quality and patient safety
Weaknesses
- Reliance on third-party payers for reimbursement
- Exposure to changes in healthcare regulations
- Competition from larger, more diversified healthcare companies
- Dependence on a limited number of key products
Opportunities
- Expanding into new geographic markets
- Developing new infusion therapies and services
- Acquiring smaller infusion providers
- Partnering with hospitals and physician groups
Threats
- Changes in reimbursement policies
- Increased competition from other infusion providers
- Drug price increases
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- CVS (CVS)
- WBA (Walgreens Boots Alliance)
- AMN (AMN Healthcare Services)
Competitive Landscape
Option Care Health competes on clinical expertise, patient service, and geographic reach. It faces competition from larger, more diversified companies with greater resources.
Major Acquisitions
Biofusion
- Year: 2021
- Acquisition Price (USD millions): 73
- Strategic Rationale: Expanded Option Care Health's presence in the Midwest and strengthened its position in the home infusion market.
Growth Trajectory and Initiatives
Historical Growth: Growth has been driven by organic expansion, acquisitions, and increasing demand for home infusion services.
Future Projections: Analyst estimates vary, but generally project continued revenue growth driven by favorable industry trends.
Recent Initiatives: Focus on expanding its geographic footprint, developing new specialty pharmacy services, and improving operational efficiency.
Summary
Option Care Health is a leading independent provider in a growing market. Their clinical focus gives them a competitive edge. Reimbursement pressures and competition from larger players are key risks. Continued growth is expected through acquisitions and expanding service offerings.
Similar Companies
- CVS
- WBA
- AMN
- LHCG
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share data is based on available estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Option Care Health Inc
Exchange NASDAQ | Headquaters Bannockburn, IL, United States | ||
IPO Launch date 1996-08-15 | CEO, President & Director Mr. John C. Rademacher | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 6015 | Website https://www.optioncarehealth.com |
Full time employees 6015 | Website https://www.optioncarehealth.com | ||
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.